\-\ Texto\\:\\ \ \(0\)\
\-\ afb\\ negative\ \(0\)\
\-\ lyme\\ ab\\ negative\ \(0\)\
\-\ fungal\\ culture\\ negative\ \(0\)\
\-\ ace\\ 55\\;\\ normal\\ 9\\-67\\.\\ \\ per\\ report\\,\\ patient\\ had\\ a\\ positive\\ ena\\ from\\ outside\\ facility\\.\ \(0\)\
\-\ patient\\ was\\ treated\\ with\\ a\\ tapering\\ dose\\ of\\ prednisone\\ and\\ is\\ being\\ followed\\ by\\ pulmonary\\ clinic\\.\ \(0\)\
\-\ plain\\ chest\\ films\\ demonstrate\\ bilateral\\ hilar\\ lymphadenopathy\\ with\\ right\\ paratracheal\\ lymphadenpathy\\ suggestive\\ of\\ sarcoid\\.\\ \\ no\\ pneumothorax\\ or\\ pleural\\ effusion\ \(0\)\
\-\ seen\\.\\ \\ pulmonary\\ vasculature\\ demonstrates\\ normal\\ caliber\\ and\\ distribution\\.\\ \\ surrounding\\ soft\\ tissues\\ and\\ osseous\\ structures\\ are\\ unremarkable\\.\\ \\ cardiac\\ silhouette\\ is\\ normal\\.\ \(0\)\
\-\ sarcoid\ \(163\)\
\-\ sarcoid\ \(163\)\
\-\ lymphoma\ \(373\)\
\-\ tuberculosis\\ or\\ other\\ oppurtunistic\\/fungal\\ disease\ \(0\)\
\-\ sjogren\\â\\€\\™s\\ syndrome\\ with\\ coexistent\\ adenopathy\ \(0\)\
\-\ patient\\ is\\ a\\ 42\\-year\\ african\\ american\\ active\\ duty\\ first\\ sergeant\\.\\ \\ patient\\ presented\\ with\\ bilateral\\ parotitis\\,\\ conjunctivitis\\,\\ xerostomia\\ and\\ shortness\\ of\\ breath\\.\ \(0\)\
\-\ sarcoid\\ is\\ a\\ systemic\\ disorder\\ of\\ unkown\\ etiology\\ characterized\\ by\\ non\\-caseating\\ granulomatous\\ inflammation\\,\\ particularly\\ of\\ the\\ lungs\\.\\ \\ onset\\ of\\ the\\ disease\\ is\\ most\\ common\\ during\\ the\\ third\\ and\\ fourth\\ decades\\.\\ \\ it\\ is\\ more\\ common\\ in\\ african\\ americans\\ and\\ women\\.\\ \\ the\\ chest\\ radiograph\\ will\\ be\\ abnormal\\ in\\ a\\ majority\\ of\\ patients\\ at\\ some\\ point\\ in\\ their\\ disease\\.\\ \\ the\\ chest\\ radiographs\\ of\\ this\\ patient\\ demonstrated\\ the\\ classic\\ radiographic\\ appearance\\ of\\ sarcoid\\,\\ which\\ is\\ right\\ paratracheal\\ and\\ symmetric\\ bilateral\\ hilar\\ lymph\\ node\\ enlargement\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ sarcoid\\:\\ 0\\.10292726819537991\ \(0\)\
\-\ paratracheal\\:\\ 0\\.05023269972926546\ \(0\)\
\-\ african\\:\\ 0\\.041866756781942786\ \(0\)\
\-\ 9\\-67\\.\\:\\ 0\\.04138741044115727\ \(0\)\
\-\ lymphadenpathy\\:\\ 0\\.04138741044115727\ \(0\)\
\-\ oppurtunistic\\/fungal\\:\\ 0\\.04138741044115727\ \(0\)\
\-\ xerostomia\\:\\ 0\\.04138741044115727\ \(0\)\
\-\ hilar\\:\\ 0\\.040316712177628715\ \(0\)\
\-\ 42\\-year\\:\\ 0\\.03813319832585236\ \(0\)\
\-\ sergeant\\:\\ 0\\.03813319832585236\ \(0\)\
\-\ parotitis\\:\\ 0\\.03813319832585236\ \(0\)\
\-\ ena\\:\\ 0\\.036229606269006516\ \(0\)\
\-\ unkown\\:\\ 0\\.036229606269006516\ \(0\)\
\-\ non\\-caseating\\:\\ 0\\.036229606269006516\ \(0\)\
\-\ negative\\:\\ 0\\.03594535438556161\ \(0\)\
\-\ coexistent\\:\\ 0\\.034878986210547455\ \(0\)\
\-\ sjogren\\:\\ 0\\.03225168204183655\ \(0\)\
\-\ conjunctivitis\\:\\ 0\\.03225168204183655\ \(0\)\
\-\ americans\\:\\ 0\\.031624774095242544\ \(0\)\
\-\ bilateral\\:\\ 0\\.02920870041287949\ \(0\)\
\-\ chest\\:\\ 0\\.028799000000810124\ \(0\)\
\-\ afb\\:\\ 0\\.028085939342301795\ \(0\)\
\-\ ace\\:\\ 0\\.028085939342301795\ \(0\)\
\-\ tapering\\:\\ 0\\.027563753261972104\ \(0\)\
\-\ ab\\:\\ 0\\.027093877869685798\ \(0\)\
\-\ decades\\:\\ 0\\.025743257811226734\ \(0\)\
\-\ lyme\\:\\ 0\\.024831727226996888\ \(0\)\
\-\ prednisone\\:\\ 0\\.02372919393555369\ \(0\)\
\-\ caliber\\:\\ 0\\.023621261925109095\ \(0\)\
\-\ pulmonary\\:\\ 0\\.023441786950423132\ \(0\)\
\-\ silhouette\\:\\ 0\\.022747542302414915\ \(0\)\
\-\ facility\\:\\ 0\\.02193607369753505\ \(0\)\
\-\ vasculature\\:\\ 0\\.02178934814117775\ \(0\)\
\-\ culture\\:\\ 0\\.021374828858803676\ \(0\)\
\-\ common\\:\\ 0\\.02099781419677368\ \(0\)\
\-\ dose\\:\\ 0\\.020993957756398188\ \(0\)\
\-\ duty\\:\\ 0\\.020933378390971393\ \(0\)\
\-\ particularly\\:\\ 0\\.0206985876840481\ \(0\)\
\-\ patient\\:\\ 0\\.020107791805549013\ \(0\)\
\-\ characterized\\:\\ 0\\.019958545692481983\ \(0\)\
\-\ majority\\:\\ 0\\.019720177967724125\ \(0\)\
\-\ disease\\:\\ 0\\.019672359735432455\ \(0\)\
\-\ women\\:\\ 0\\.019493330187110008\ \(0\)\
\-\ fungal\\:\\ 0\\.01944924689908259\ \(0\)\
\-\ 55\\:\\ 0\\.01944924689908259\ \(0\)\
\-\ fourth\\:\\ 0\\.019405573694095204\ \(0\)\
\-\ granulomatous\\:\\ 0\\.019362303012851433\ \(0\)\
\-\ systemic\\:\\ 0\\.01919310143311811\ \(0\)\
\-\ tuberculosis\\:\\ 0\\.019110733782174875\ \(0\)\
\-\ american\\:\\ 0\\.019110733782174875\ \(0\)\
\-\ normal\\:\\ 0\\.018867781050691566\ \(0\)\
\-\ pneumothorax\\:\\ 0\\.018833321029264046\ \(0\)\
\-\ is\\:\\ 0\\.018479039665225728\ \(0\)\
\-\ node\\:\\ 0\\.01835795138745572\ \(0\)\
\-\ symmetric\\:\\ 0\\.018323302996387073\ \(0\)\
\-\ distribution\\:\\ 0\\.01805495363563614\ \(0\)\
\-\ disorder\\:\\ 0\\.018022463293642835\ \(0\)\
\-\ report\\:\\ 0\\.01795814947036508\ \(0\)\
\-\ clinic\\:\\ 0\\.0179263199540018\ \(0\)\
\-\ adenopathy\\:\\ 0\\.017863301079203017\ \(0\)\
\-\ per\\:\\ 0\\.017560303327383432\ \(0\)\
\-\ their\\:\\ 0\\.017560303327383432\ \(0\)\
\-\ point\\:\\ 0\\.01753105192010345\ \(0\)\
\-\ suggestive\\:\\ 0\\.017139588967337954\ \(0\)\
\-\ lymphadenopathy\\:\\ 0\\.017059788139316495\ \(0\)\
\-\ inflammation\\:\\ 0\\.017059788139316495\ \(0\)\
\-\ osseous\\:\\ 0\\.01703348647007391\ \(0\)\
\-\ etiology\\:\\ 0\\.01698132109249142\ \(0\)\
\-\ shortness\\:\\ 0\\.016878697647362318\ \(0\)\
\-\ outside\\:\\ 0\\.016828215056863435\ \(0\)\
\-\ films\\:\\ 0\\.016559865696112504\ \(0\)\
\-\ tissues\\:\\ 0\\.016465965852419218\ \(0\)\
\-\ lymph\\:\\ 0\\.016195034783777686\ \(0\)\
\-\ third\\:\\ 0\\.01608660419788731\ \(0\)\
\-\ enlargement\\:\\ 0\\.015918161532793875\ \(0\)\
\-\ pleural\\:\\ 0\\.015579108913959137\ \(0\)\
\-\ structures\\:\\ 0\\.015446316830209927\ \(0\)\
\-\ classic\\:\\ 0\\.015372088632901747\ \(0\)\
\-\ active\\:\\ 0\\.015317177648098031\ \(0\)\
\-\ cardiac\\:\\ 0\\.015280923910567935\ \(0\)\
\-\ effusion\\:\\ 0\\.015244947982184983\ \(0\)\
\-\ radiographic\\:\\ 0\\.015227062872247576\ \(0\)\
\-\ lungs\\:\\ 0\\.015191495765165614\ \(0\)\
\-\ breath\\:\\ 0\\.015000551916663607\ \(0\)\
\-\ being\\:\\ 0\\.01398022524319511\ \(0\)\
\-\ first\\:\\ 0\\.01346236354359555\ \(0\)\
\-\ followed\\:\\ 0\\.013450121461872166\ \(0\)\
\-\ by\\:\\ 0\\.013360290171313379\ \(0\)\
\-\ unremarkable\\:\\ 0\\.013282001965643478\ \(0\)\
\-\ surrounding\\:\\ 0\\.013188569316266505\ \(0\)\
\-\ plain\\:\\ 0\\.013029407101826688\ \(0\)\
\-\ positive\\:\\ 0\\.013018242207906651\ \(0\)\
\-\ radiograph\\:\\ 0\\.012779101661602642\ \(0\)\
\-\ radiographs\\:\\ 0\\.012705496907052267\ \(0\)\
\-\ onset\\:\\ 0\\.012663949417488968\ \(0\)\
\-\ will\\:\\ 0\\.01255155407689738\ \(0\)\
\-\ during\\:\\ 0\\.012277038732036658\ \(0\)\
\-\ some\\:\\ 0\\.012182761755243\ \(0\)\
\-\ treated\\:\\ 0\\.012008689371285724\ \(0\)\
\-\ \\â\\€\\™\\:\\ 0\\.011990735866880075\ \(0\)\
\-\ demonstrated\\:\\ 0\\.011771924800267453\ \(0\)\
\-\ s\\:\\ 0\\.011505951488800879\ \(0\)\
\-\ syndrome\\:\\ 0\\.011473739796876251\ \(0\)\
\-\ appearance\\:\\ 0\\.011473739796876251\ \(0\)\
\-\ lymphoma\\:\\ 0\\.011465721288213548\ \(0\)\
\-\ abnormal\\:\\ 0\\.01144174760711226\ \(0\)\
\-\ presented\\:\\ 0\\.010935951338133377\ \(0\)\
\-\ patients\\:\\ 0\\.010382979339746601\ \(0\)\
\-\ more\\:\\ 0\\.010033691593014865\ \(0\)\
\-\ soft\\:\\ 0\\.009769609220626996\ \(0\)\
\-\ \\;\\:\\ 0\\.009509019664096684\ \(0\)\
\-\ or\\:\\ 0\\.009403969473837629\ \(0\)\
\-\ a\\:\\ 0\\.009309854502784067\ \(0\)\
\-\ most\\:\\ 0\\.00926213681562477\ \(0\)\
\-\ other\\:\\ 0\\.009247129336631214\ \(0\)\
\-\ demonstrate\\:\\ 0\\.00923216967761991\ \(0\)\
\-\ it\\:\\ 0\\.009018067533018858\ \(0\)\
\-\ demonstrates\\:\\ 0\\.00876347981996801\ \(0\)\
\-\ had\\:\\ 0\\.00865657192131788\ \(0\)\
\-\ right\\:\\ 0\\.008466025437656495\ \(0\)\
\-\ seen\\:\\ 0\\.00792782917872155\ \(0\)\
\-\ which\\:\\ 0\\.007488941724143421\ \(0\)\
\-\ \\,\\:\\ 0\\.006354696373645243\ \(0\)\
\-\ be\\:\\ 0\\.0061866512833048315\ \(0\)\
\-\ from\\:\\ 0\\.005945707573493954\ \(0\)\
\-\ in\\:\\ 0\\.005935172255496548\ \(0\)\
\-\ and\\:\\ 0\\.0059157889207771324\ \(0\)\
\-\ are\\:\\ 0\\.005468891420326769\ \(0\)\
\-\ at\\:\\ 0\\.005435507759772925\ \(0\)\
\-\ of\\:\\ 0\\.004922695808365708\ \(0\)\
\-\ was\\:\\ 0\\.004639800573773178\ \(0\)\
\-\ this\\:\\ 0\\.004512381283164944\ \(0\)\
\-\ no\\:\\ 0\\.00403964390001785\ \(0\)\
\-\ the\\:\\ 0\\.003894346047989459\ \(0\)\
\-\ \\.\\:\\ 0\\.002333302842079098\ \(0\)\
\-\ with\\:\\ 0\\.0021972615228148308\ \(0\)\
